Daniela C. Granato
Campinas, SP 13083100, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
The clinical promise of mass spectrometry-based single-cell proteomics: from bedside to bench.
Journal: Expert review of proteomics
Published: July 09, 2026
Mapping the Interactome of OSCC Prognostic-Associated Proteins NDRG1 and PGK1 Through Proximity Labeling Using TurboID.
Journal: Journal of proteome research
Published: April 30, 2025
Noninvasive and Sensitive Biosensor for the Detection of Oral Cancer Prognostic Biomarkers.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: April 06, 2025
Mapping Conformational Changes in the Saliva Proteome Potentially Associated with Oral Cancer Aggressiveness.
Journal: Journal of proteome research
Published: May 24, 2024
Peptidomics Strategies to Evaluate Cancer Diagnosis, Prognosis, and Treatment.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 29, 2024
Uncovering the bookshelves of CRISPR-based libraries: Advances and applications in cancer studies.
Journal: Critical reviews in oncology/hematology
Published: December 01, 2023
Typic: A Practical and Robust Tool to Rank Proteotypic Peptides for Targeted Proteomics.
Journal: Journal of proteome research
Published: December 08, 2022
A meta-analysis reveals the protein profile associated with malignant transformation of oral leukoplakia.
Journal: Frontiers in oral health
Published: November 02, 2022
Corrigendum to: "Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models" [J Proteomics. 2022 Jan 3:104474. doi: 10.1016/j.jprot.2021.104474. Online ahead of print. PMID: 34990821].
Journal: Journal of proteomics
Published: March 04, 2022
Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancer.
Journal: Nature communications
Published: January 21, 2022
Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models.
Journal: Journal of proteomics
Published: July 11, 2021
STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma.
Journal: Neoplasia (New York, N.Y.)
Published: May 07, 2021
Last Updated: 09/26/2026